The latter theory is supported by observations suggesting that impaired insulin action in early pregnancy is per se contributing to fetal adiposity (due to hyperinsulinism and placental changes leading to increased nutrient supply to the offspring) but is also acting as a risk factor for the need of glucose lowering medication as described above (7, 18). Here, INS is linked to hyperinsulinism.